Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis.

Noton EA, Colnaghi R, Tate S, Starck C, Carvalho A, Ko Ferrigno P, Wheatley SP.

J Biol Chem. 2006 Jan 13;281(2):1286-95. Epub 2005 Nov 16.

2.

The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.

Knauer SK, Bier C, Schlag P, Fritzmann J, Dietmaier W, Rödel F, Klein-Hitpass L, Kovács AF, Döring C, Hansmann ML, Hofmann WK, Kunkel M, Brochhausen C, Engels K, Lippert BM, Mann W, Stauber RH.

Cell Cycle. 2007 Jun 15;6(12):1502-9. Epub 2007 Apr 15.

PMID:
17582222
3.

Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?

Wuttig D, Kunze D, Fuessel S, Toma M, Stade J, Kotzsch M, Kappler M, Taubert H, Schwenzer B, Baretton G, Hakenberg OW, Meye A, Wirth MP.

Int J Oncol. 2007 Jun;30(6):1317-24.

PMID:
17487351
4.

Survivin splice variants regulate the balance between proliferation and cell death.

Caldas H, Jiang Y, Holloway MP, Fangusaro J, Mahotka C, Conway EM, Altura RA.

Oncogene. 2005 Mar 17;24(12):1994-2007.

PMID:
15688031
5.

Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.

Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K.

Urology. 2008 Dec;72(6):1229-33. doi: 10.1016/j.urology.2007.12.064. Epub 2008 Mar 12.

PMID:
18336887
6.

Differential subcellular localization of functionally divergent survivin splice variants.

Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD.

Cell Death Differ. 2002 Dec;9(12):1334-42.

7.

Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).

Ling X, Yang J, Tan D, Ramnath N, Younis T, Bundy BN, Slocum HK, Yang L, Zhou M, Li F.

Lung Cancer. 2005 Sep;49(3):353-61.

8.

The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin.

Bourhis E, Hymowitz SG, Cochran AG.

J Biol Chem. 2007 Nov 30;282(48):35018-23. Epub 2007 Sep 19.

9.

Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.

Suga K, Yamamoto T, Yamada Y, Miyatake S, Nakagawa T, Tanigawa N.

Oncol Rep. 2005 May;13(5):891-7.

PMID:
15809755
10.

Distinct dynamics of Aurora B and Survivin during mitosis.

Delacour-Larose M, Molla A, Skoufias DA, Margolis RL, Dimitrov S.

Cell Cycle. 2004 Nov;3(11):1418-26. Epub 2004 Nov 3.

PMID:
15483398
11.

Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.

Atlasi Y, Mowla SJ, Ziaee SA.

Cancer Detect Prev. 2009;32(4):308-13. doi: 10.1016/j.cdp.2008.12.001. Epub 2009 Jan 30.

PMID:
19186007
12.
13.

Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer.

Okamura K, Koike H, Sekine Y, Matsui H, Suzuki K.

Cancer Epidemiol. 2009 Aug;33(2):137-41. doi: 10.1016/j.canep.2009.06.005.

PMID:
19679061
14.

Survivin modulates microtubule dynamics and nucleation throughout the cell cycle.

Rosa J, Canovas P, Islam A, Altieri DC, Doxsey SJ.

Mol Biol Cell. 2006 Mar;17(3):1483-93. Epub 2006 Jan 11.

15.

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.

Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill AD, McDermott E, O'Higgins N, Duffy MJ.

Br J Cancer. 2005 Jan 17;92(1):120-4.

16.

Nuclear survivin has reduced stability and is not cytoprotective.

Connell CM, Colnaghi R, Wheatley SP.

J Biol Chem. 2008 Feb 8;283(6):3289-96. Epub 2007 Dec 5.

17.

Distinct expression of Survivin splice variants in breast carcinomas.

Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S.

Int J Oncol. 2005 Oct;27(4):1151-7.

PMID:
16142334
18.

Survivin: a protein with dual roles in mitosis and apoptosis.

Wheatley SP, McNeish IA.

Int Rev Cytol. 2005;247:35-88. Review.

PMID:
16344111
19.

Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.

Malcles MH, Wang HW, Koumi A, Tsai YH, Yu M, Godfrey A, Boshoff C.

Br J Cancer. 2007 Jun 4;96(11):1659-66. Epub 2007 May 15.

20.

Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.

Caldas H, Fangusaro JR, Boué DR, Holloway MP, Altura RA.

Blood. 2007 Feb 15;109(4):1479-89. Epub 2006 Oct 12.

Items per page

Supplemental Content

Write to the Help Desk